Cytokinetics to Present Clinical Trial Data Relating to Tirasemtiv in Patients with Myasthenia Gravis

[at noodls] – Phase IIa data to be Presented at the 65th Annual Meeting of the American Academy of Neurology South San Francisco, CA – March 13, 2013 Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that an … more

View todays social media effects on CYTK

View the latest stocks trending across Twitter. Click to view dashboard

See who Cytokinetics is hiring next, click here to view